Stock VIRALYTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Viralytics Ltd. Stock Other OTC

Equities

Biotechnology & Medical Research

Chart Viralytics Ltd.

Dynamic Chart

Latest news about Viralytics Ltd.

Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million RE
More news

Analyst Recommendations on Viralytics Ltd.

Viralytics : ROTH Capital Partners - Updated Research Note PU
More recommendations

Press releases Viralytics Ltd.

Viralytics : Chairman’s letter to shareholders PU
Viralytics : New Data Presented at SITC Annual Meeting PU
Viralytics : Annual Report and Full Year Financial Results PU
Viralytics : Newsletter PU
Viralytics : Positive Bio-Marker Data from CANON Study PU
More press releases

News in other languages on Viralytics Ltd.

Immunothérapie: Merck & Co achète l'australien Viralytics
More news

Managers and Directors - Viralytics Ltd.

Managers TitleAgeSince
Georgina Diab SEC
 Corporate Secretary - 18-06-19
Jennifer Rosenthal PRN
 Corporate Officer/Principal - -
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+20.17% 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+24.67% 118B
ARGENX SE Stock argenx SE
+24.98% 27.87B
BIONTECH SE Stock BioNTech SE
-17.74% 20.95B
GENMAB A/S Stock Genmab A/S
-15.15% 16.92B
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.21% 16.18B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+11.91% 14.84B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-47.10% 14.79B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+54.50% 14.08B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VLA Stock
  4. Stock